Akiharu Isowaki is a notable inventor based in Woodland Hills, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of innovative transdermal drug delivery systems. With a total of 2 patents to his name, Isowaki's work focuses on improving treatment options for eyelid diseases.

Latest Patents

Isowaki's latest patents include a "Patch for treatment of eyelid disease containing clobetasol" and a "Transdermal drug delivery system and method of using the same." The first patent describes a patch designed for treating eyelid diseases, which features a support, a pressure-sensitive adhesive layer, and a release layer. The adhesive layer contains a specific combination of materials, including a styrene-isoprene-styrene block copolymer and clobetasol, ensuring effective delivery of the medication. The second patent outlines a transdermal drug delivery system that utilizes steroids as active agents, allowing for the treatment of various eyelid conditions such as chalazion and blepharitis.

Career Highlights

Throughout his career, Akiharu Isowaki has worked with reputable companies, including Senju USA, Inc. and Nichiban Company Limited. His experience in these organizations has contributed to his expertise in developing advanced medical solutions.

Collaborations

Isowaki has collaborated with talented individuals in the field, including Takahiro Ogawa and Koji Kawahara. These partnerships have fostered innovation and enhanced the quality of his inventions.

Conclusion

Akiharu Isowaki's contributions to transdermal drug delivery systems demonstrate his commitment to improving healthcare solutions. His innovative patents and collaborations highlight his role as a key figure in the medical technology landscape.

This text is generated by artificial intelligence and may not be accurate.